Key points are not available for this paper at this time.
The Food and Drug Administration (FDA) is known for its rigor in regulating drugs, not devices. That may be about to change. In recent years, well-publicized device recalls and lawsuits have led to complaints that the FDA does not do enough to keep unsafe devices off the market. The failure of some devices, such as implantable defibrillators, could pose deadly risks.Fundamental differences between devices and drugs have important implications for FDA regulation. A typical device is an engineered product, rather than a chemical compound like a conventional drug or a biologic agent. The effects of a minor modification in . . .
Building similarity graph...
Analyzing shared references across papers
Loading...
Alan M. Garber
New England Journal of Medicine
VA Palo Alto Health Care System
Building similarity graph...
Analyzing shared references across papers
Loading...
Alan M. Garber (Thu,) studied this question.
synapsesocial.com/papers/6a1cf1b1107f098821899e75 — DOI: https://doi.org/10.1056/nejmp1000447
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: